NCT03287089View on ClinicalTrials.gov

Nitrofurantoin Administration for the Prevention of Short-Term Catheter Associated Urinary Tract Infection After Pelvic Surgery

PHASE4CompletedINTERVENTIONAL

Enrollment

164

Participants

Timeline

Start Date

September 29, 2017

Primary Completion Date

May 30, 2019

Study Completion Date

June 1, 2019

Conditions

Catheter-Associated Urinary Tract Infection

Interventions

DRUG

Nitrofurantoin 100 MG

Patients will receive nitrofurantoin 100mg twice daily by mouth for 5 days

DRUG

Placebo Oral Tablet

Matching placebo

Trial Locations (1)

28207

Atrium Health, Charlotte

All Listed Sponsors

lead

Wake Forest University Health Sciences

OTHER

NCT03287089 - Nitrofurantoin Administration for the Prevention of Short-Term Catheter Associated Urinary Tract Infection After Pelvic Surgery | Biotech Hunter | Biotech Hunter